- BioRN Network
- Cluster Management
About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar (BioRN). Globally acting healthcare companies as well as internationally renowned research institutes also play a significant part in this development.
With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”
August 27, 2014
Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide
August 26, 2014
DKFZ: One cancer – many tumors
August 25, 2014
Roche and InterMune reach definitive merger agreement
Read our monthly BioRN Newsletter. It will keep you informed about what´s going on in the BioRN cluster.
» Find further future events here